2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Plus Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on April 22, 2021
AUSTIN, Texas, April 08, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel,...
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...
Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for...
MediPharm Labs Completes Its First High THC Cannabis Oil Export to Peru
MediPharm Labs’ high THC medical cannabis has been successfully exported to Peru for distribution by specialized compounding pharmaciesPeru marks MediPharm...
THC Therapeutics Engage Milestone Management Services for Investor Relations
LAS VEGAS, April 08, 2021 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded health and technology company, whose...
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
Featuring leading neurologist Marwan Sabbagh, M.DWebinar to be held Thursday, April 15, at 1:30 p.m. PT / 4:30 p.m. ETBOTHELL,...
Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
REDWOOD CITY, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new...
Akouos to Present at 20th Annual Needham Virtual Healthcare Conference
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing...
Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions
Value of KidneyIntelX Testing Demonstrated by Data from 401 Physician Study Presented at National Kidney Foundation 2021 Spring Clinical MeetingsNEW...
CareDx Announces New HLA Typing Service Offering for Research Purposes
Initial projects underway for global pharmaceutical companySOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA),...
Sigilon Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
BBS-Bioactive Bone Substitutes Plc: CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING
BBS-Bioactive Bone Substitutes Plc: CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING Stock Exchange Release April 8th, 2021 at 02.00...
Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial
VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis
Biogen enters into a commercialization and license agreement to develop, manufacture and commercialize BAT1806, a proposed biosimilar referencing ACTEMRA® (tocilizumab)Biosimilars...
CENTOGENE to Announce Full Year 2020 Financial Results on April 15, 2021
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 08, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company...
TCR² Therapeutics to Present at the Needham Healthcare Conference
CAMBRIDGE, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a...
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
The Company realized significant Q1 revenue growth due to increased online retail sales and proceeds from a licensing agreementLOS ANGELES,...
Affimed to Report Full Year 2020 Financial Results & Corporate Update on April 15, 2021
Heidelberg, Germany, April 8, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their...